Search Results

You are looking at 1 - 10 of 261 items for :

  • "gastroenteropancreatic" x
  • Refine by access: All content x
Clear All
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Sciences, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed
Close
,
Grace Kong Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia

Search for other papers by Grace Kong in
Google Scholar
PubMed
Close
, and
Simona Grozinsky-Glasberg Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Close

, there is relatively high consistency in the effectiveness of PRRT for gastroenteropancreatic (GEP) NET, with an encouraging 40% response rate (RR), 80% disease control rate (DCR) and long overall survival (OS) ( Brabander et al . 2017 , Hicks et al

Free access
Andreas Venizelos K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Andreas Venizelos in
Google Scholar
PubMed
Close
,
Hege Elvebakken Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

Search for other papers by Hege Elvebakken in
Google Scholar
PubMed
Close
,
Aurel Perren Institute of Pathology, University of Bern, Bern, Switzerland

Search for other papers by Aurel Perren in
Google Scholar
PubMed
Close
,
Oleksii Nikolaienko K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Oleksii Nikolaienko in
Google Scholar
PubMed
Close
,
Wei Deng K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Wei Deng in
Google Scholar
PubMed
Close
,
Inger Marie B Lothe Department of Pathology, Oslo University Hospital, Oslo, Norway

Search for other papers by Inger Marie B Lothe in
Google Scholar
PubMed
Close
,
Anne Couvelard Department of Pathology, Université de Paris, Bichat Hospital, AP-HP, Paris, France

Search for other papers by Anne Couvelard in
Google Scholar
PubMed
Close
,
Geir Olav Hjortland Department of Oncology, Oslo University Hospital, Oslo, Norway

Search for other papers by Geir Olav Hjortland in
Google Scholar
PubMed
Close
,
Anna Sundlöv Departmentt of Oncology, Skåne University Hospital, Lund, Sweden
Department of Medical Radiation Physics, Lund University, Lund, Sweden

Search for other papers by Anna Sundlöv in
Google Scholar
PubMed
Close
,
Johanna Svensson Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Johanna Svensson in
Google Scholar
PubMed
Close
,
Harrish Garresori Department of Oncology, Stavanger University Hospital, Stavanger, Norway

Search for other papers by Harrish Garresori in
Google Scholar
PubMed
Close
,
Christian Kersten Department of Research, Hospital of Southern Norway, Kristiansand, Norway

Search for other papers by Christian Kersten in
Google Scholar
PubMed
Close
,
Eva Hofsli Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
Department of Oncology, St.Olavs Hospital, Trondheim, Norway

Search for other papers by Eva Hofsli in
Google Scholar
PubMed
Close
,
Sönke Detlefsen Department of Pathology, Odense University Hospital, Odense, Denmark
Department of Clinical Medicine, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark

Search for other papers by Sönke Detlefsen in
Google Scholar
PubMed
Close
,
Merete Krogh Department of Oncology, Odense University Hospital, Odense, Denmark

Search for other papers by Merete Krogh in
Google Scholar
PubMed
Close
,
Halfdan Sorbye Department of Oncology, Haukeland University Hospital, Bergen, Norway
Department of Clinical Science, University of Bergen, Bergen, Norway

Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed
Close
, and
Stian Knappskog K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway
Department of Oncology, Haukeland University Hospital, Bergen, Norway

Search for other papers by Stian Knappskog in
Google Scholar
PubMed
Close

Introduction High-grade (HG) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) are defined by the presence of neuroendocrine phenotype and a high proliferation rate (Ki-67 > 20%). The HG NEN entity consists of well

Open access
Andrew McDonald Winship Cancer Institute at Emory University, Atlanta, Georgia, USA

Search for other papers by Andrew McDonald in
Google Scholar
PubMed
Close
,
Vaidehi Avadhani Grady Memorial Hospital, Atlanta, Georgia, USA

Search for other papers by Vaidehi Avadhani in
Google Scholar
PubMed
Close
,
Gabriela Oprea-Ilies Grady Memorial Hospital, Atlanta, Georgia, USA

Search for other papers by Gabriela Oprea-Ilies in
Google Scholar
PubMed
Close
,
Katerina Zakka Winship Cancer Institute at Emory University, Atlanta, Georgia, USA

Search for other papers by Katerina Zakka in
Google Scholar
PubMed
Close
,
Gregory B Lesinski Winship Cancer Institute at Emory University, Atlanta, Georgia, USA

Search for other papers by Gregory B Lesinski in
Google Scholar
PubMed
Close
,
Olumide B Gbolahan Winship Cancer Institute at Emory University, Atlanta, Georgia, USA

Search for other papers by Olumide B Gbolahan in
Google Scholar
PubMed
Close
, and
Olatunji Alese Winship Cancer Institute at Emory University, Atlanta, Georgia, USA

Search for other papers by Olatunji Alese in
Google Scholar
PubMed
Close

Introduction Neuroendocrine neoplasms (NENs) of the gastroenteropancreatic (GEP) system are a heterogeneous group of rare malignancies. While the incidence of NENs was relatively low, with 6.98 cases per 100,000 adults in 2012, the incidence

Restricted access
Florian Bösch Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by Florian Bösch in
Google Scholar
PubMed
Close
,
Katharina Brüwer Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by Katharina Brüwer in
Google Scholar
PubMed
Close
,
Annelore Altendorf-Hofmann Department of General, Visceral und Vascular Surgery, Friedrich-Schiller University, Jena, Germany

Search for other papers by Annelore Altendorf-Hofmann in
Google Scholar
PubMed
Close
,
Christoph J Auernhammer Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Christoph J Auernhammer in
Google Scholar
PubMed
Close
,
Christine Spitzweg Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Internal Medicine 4, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Christine Spitzweg in
Google Scholar
PubMed
Close
,
C Benedikt Westphalen Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Medicine 3 and Comprehensive Cancer Center, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by C Benedikt Westphalen in
Google Scholar
PubMed
Close
,
Stefan Boeck Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Medicine 3 and Comprehensive Cancer Center, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Stefan Boeck in
Google Scholar
PubMed
Close
,
Gabriele Schubert-Fritschle Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Munich Cancer Registry (MCR) of the Munich Tumour Centre (TZM), Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Gabriele Schubert-Fritschle in
Google Scholar
PubMed
Close
,
Jens Werner Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by Jens Werner in
Google Scholar
PubMed
Close
,
Volker Heinemann Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Department of Medicine 3 and Comprehensive Cancer Center, Ludwig-Maximilians-University Munich, Munich, Germany

Search for other papers by Volker Heinemann in
Google Scholar
PubMed
Close
,
Thomas Kirchner Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany

Search for other papers by Thomas Kirchner in
Google Scholar
PubMed
Close
,
Martin Angele Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany
Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany

Search for other papers by Martin Angele in
Google Scholar
PubMed
Close
, and
Thomas Knösel Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System, Ludwig-Maximilians-University of Munich, Munich, Germany
Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany

Search for other papers by Thomas Knösel in
Google Scholar
PubMed
Close

, Lawrence et al . 2011 ). Thus, NENs are nowadays as frequent as testicular tumors, Hodgkin’s disease, gliomas and multiple myeloma ( Modlin et al . 2008 ). Gastroenteropancreatic NENs (GEP-NENs) represent the preponderance with primaries localized in the

Free access
Taymeyah Al-Toubah Department of GI Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Search for other papers by Taymeyah Al-Toubah in
Google Scholar
PubMed
Close
,
Stefano Partelli Pancreas Translational & Clinical Research Center, Ospedale San Raffaele IRCCS, Milano, Italy
Università, Vita e Salute, Milan, Italy

Search for other papers by Stefano Partelli in
Google Scholar
PubMed
Close
,
Mauro Cives Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy

Search for other papers by Mauro Cives in
Google Scholar
PubMed
Close
,
Valentina Andreasi Pancreas Translational & Clinical Research Center, Ospedale San Raffaele IRCCS, Milano, Italy

Search for other papers by Valentina Andreasi in
Google Scholar
PubMed
Close
,
Franco Silvestris Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy

Search for other papers by Franco Silvestris in
Google Scholar
PubMed
Close
,
Massimo Falconi Pancreas Translational & Clinical Research Center, Ospedale San Raffaele IRCCS, Milano, Italy
Università, Vita e Salute, Milan, Italy

Search for other papers by Massimo Falconi in
Google Scholar
PubMed
Close
,
Daniel A Anaya Department of GI Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Search for other papers by Daniel A Anaya in
Google Scholar
PubMed
Close
, and
Jonathan Strosberg Department of GI Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Search for other papers by Jonathan Strosberg in
Google Scholar
PubMed
Close

Introduction Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a heterogeneous group of tumors which include NETs of the gastrointestinal tract and pancreas. Tumor grade and differentiation are important prognostic factors. Low

Free access
Günter Klöppel Department of Pathology, Technical University of München, Ismaninger Strasse 22, 81675 München, Germany

Search for other papers by Günter Klöppel in
Google Scholar
PubMed
Close

, but is not specific for these tumours ( Klöppel et al . 2009 ). Under the electron microscope the NENs show typical neurosecretory granules. This review deals with the classification of the gastroenteropancreatic NENs (GEP-NENs) and discusses briefly

Free access
Nicole Panarelli Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA

Search for other papers by Nicole Panarelli in
Google Scholar
PubMed
Close
,
Kathrin Tyryshkin Laboratory of Translational RNA Biology, Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Kathrin Tyryshkin in
Google Scholar
PubMed
Close
,
Justin Jong Mun Wong Laboratory of Translational RNA Biology, Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Justin Jong Mun Wong in
Google Scholar
PubMed
Close
,
Adrianna Majewski Laboratory of Translational RNA Biology, Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Adrianna Majewski in
Google Scholar
PubMed
Close
,
Xiaojing Yang Laboratory of Translational RNA Biology, Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Xiaojing Yang in
Google Scholar
PubMed
Close
,
Theresa Scognamiglio Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA

Search for other papers by Theresa Scognamiglio in
Google Scholar
PubMed
Close
,
Michelle Kang Kim Center for Carcinoid and Neuroendocrine Tumors of Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA

Search for other papers by Michelle Kang Kim in
Google Scholar
PubMed
Close
,
Kimberly Bogardus HHMI, Laboratory of RNA Molecular Biology, The Rockefeller University, New York, New York, USA

Search for other papers by Kimberly Bogardus in
Google Scholar
PubMed
Close
,
Thomas Tuschl HHMI, Laboratory of RNA Molecular Biology, The Rockefeller University, New York, New York, USA

Search for other papers by Thomas Tuschl in
Google Scholar
PubMed
Close
,
Yao-Tseng Chen Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA

Search for other papers by Yao-Tseng Chen in
Google Scholar
PubMed
Close
, and
Neil Renwick Laboratory of Translational RNA Biology, Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
HHMI, Laboratory of RNA Molecular Biology, The Rockefeller University, New York, New York, USA

Search for other papers by Neil Renwick in
Google Scholar
PubMed
Close

Introduction Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are increasingly common and clinically diverse neoplasms ( Yao et al . 2008 , Lawrence et al . 2011 ) that are challenging to evaluate histologically ( Klimstra 2016

Free access
Bristi Basu Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Search for other papers by Bristi Basu in
Google Scholar
PubMed
Close
,
Bhawna Sirohi Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Search for other papers by Bhawna Sirohi in
Google Scholar
PubMed
Close
, and
Pippa Corrie Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK

Search for other papers by Pippa Corrie in
Google Scholar
PubMed
Close

Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumours . Journal of Nuclear Medicine 47 223 – 233 . Faiss S Scherubl H Riecken EO

Free access
Atsuko Kasajima Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany
Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Atsuko Kasajima in
Google Scholar
PubMed
Close
,
Marianne Pavel Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Marianne Pavel in
Google Scholar
PubMed
Close
,
Silvia Darb-Esfahani Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Silvia Darb-Esfahani in
Google Scholar
PubMed
Close
,
Aurelia Noske Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Aurelia Noske in
Google Scholar
PubMed
Close
,
Albrecht Stenzinger Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany
Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Albrecht Stenzinger in
Google Scholar
PubMed
Close
,
Hironobu Sasano Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Hironobu Sasano in
Google Scholar
PubMed
Close
,
Manfred Dietel Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Manfred Dietel in
Google Scholar
PubMed
Close
,
Carsten Denkert Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Carsten Denkert in
Google Scholar
PubMed
Close
,
Christoph Röcken Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Christoph Röcken in
Google Scholar
PubMed
Close
,
Bertram Wiedenmann Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Bertram Wiedenmann in
Google Scholar
PubMed
Close
, and
Wilko Weichert Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany
Institute of Pathology, Department of Internal Medicine, Department of Pathology, Institute of Pathology, Institute of Pathology, Institute of Pathology, Charité Universitätsmedizin, Berlin, Germany

Search for other papers by Wilko Weichert in
Google Scholar
PubMed
Close

Introduction With an incidence rate of about 2.5–5 cases per 100 000 person-years, gastroenteropancreatic neuroendocrine tumours (GEP-NET) are rather rare neoplasms when compared with adenocarcinomas of the same locations ( Modlin et al . 2008

Free access
Georgios K Dimitriadis The Arden NET CoE, Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals of Coventry and Warwickshire NHS Trust, Coventry, UK
Division of Translational and Experimental Medicine, Warwick Medical School, University of Warwick, Coventry, UK
Division of Endocrinology and Investigative Medicine, Imperial College London, Hammersmith Campus, London, UK

Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Close
,
Martin O Weickert The Arden NET CoE, Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals of Coventry and Warwickshire NHS Trust, Coventry, UK
Division of Translational and Experimental Medicine, Warwick Medical School, University of Warwick, Coventry, UK
Centre for Applied Biological and Exercise Sciences, Coventry University, Coventry, UK

Search for other papers by Martin O Weickert in
Google Scholar
PubMed
Close
,
Harpal S Randeva The Arden NET CoE, Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals of Coventry and Warwickshire NHS Trust, Coventry, UK
Division of Translational and Experimental Medicine, Warwick Medical School, University of Warwick, Coventry, UK
Centre for Applied Biological and Exercise Sciences, Coventry University, Coventry, UK

Search for other papers by Harpal S Randeva in
Google Scholar
PubMed
Close
,
Gregory Kaltsas The Arden NET CoE, Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism, University Hospitals of Coventry and Warwickshire NHS Trust, Coventry, UK
Division of Pathophysiology, National and Kapodistrian University of Athens Medical School, Athens, Greece
Oxford Center for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
Close
, and
Ashley Grossman Oxford Center for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK

Search for other papers by Ashley Grossman in
Google Scholar
PubMed
Close

Introduction Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are considered to be relatively rare, with an estimated incidence of 3–5 cases per 100,000 inhabitants; however, recent data indicate that their prevalence is increasing

Free access